JP4917712B2 - 併用医薬 - Google Patents

併用医薬 Download PDF

Info

Publication number
JP4917712B2
JP4917712B2 JP2001047695A JP2001047695A JP4917712B2 JP 4917712 B2 JP4917712 B2 JP 4917712B2 JP 2001047695 A JP2001047695 A JP 2001047695A JP 2001047695 A JP2001047695 A JP 2001047695A JP 4917712 B2 JP4917712 B2 JP 4917712B2
Authority
JP
Japan
Prior art keywords
administration
insulin secretagogue
voglibose
repaglinide
glucosidase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2001047695A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001316293A (ja
JP2001316293A5 (enExample
Inventor
泰雄 杉山
裕之 小高
寛 ▲さき▼山
真人 岩崎
雅美 舟津
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to JP2001047695A priority Critical patent/JP4917712B2/ja
Publication of JP2001316293A publication Critical patent/JP2001316293A/ja
Publication of JP2001316293A5 publication Critical patent/JP2001316293A5/ja
Application granted granted Critical
Publication of JP4917712B2 publication Critical patent/JP4917712B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2001047695A 2000-02-24 2001-02-23 併用医薬 Expired - Lifetime JP4917712B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001047695A JP4917712B2 (ja) 2000-02-24 2001-02-23 併用医薬

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000-52297 2000-02-24
JP2000052297 2000-02-24
JP2000052297 2000-02-24
JP2001047695A JP4917712B2 (ja) 2000-02-24 2001-02-23 併用医薬

Publications (3)

Publication Number Publication Date
JP2001316293A JP2001316293A (ja) 2001-11-13
JP2001316293A5 JP2001316293A5 (enExample) 2007-08-16
JP4917712B2 true JP4917712B2 (ja) 2012-04-18

Family

ID=26586285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001047695A Expired - Lifetime JP4917712B2 (ja) 2000-02-24 2001-02-23 併用医薬

Country Status (1)

Country Link
JP (1) JP4917712B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1552830A4 (en) * 2002-06-28 2007-07-18 Kissei Pharmaceutical DRUG COMPOSITION FOR PREVENTING OR INHIBITING PROGRESSION OF DIABETES COMPLICATIONS
WO2004002473A1 (ja) * 2002-06-28 2004-01-08 Kissei Pharmaceutical Co., Ltd. 血糖コントロール用医薬組成物
JP2004067575A (ja) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd 糖尿病治療薬効果促進剤
WO2005074909A1 (ja) * 2004-02-09 2005-08-18 Aska Pharmaceutical Co., Ltd. 併用医薬
CA2605302A1 (en) 2005-04-20 2006-11-02 Kissei Pharmaceutical Co., Ltd. Combined pharmaceutical preparation for treatment of type 2 diabetes
JP5678477B2 (ja) 2009-05-28 2015-03-04 旭硝子株式会社 光学ガラス

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715298D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
JPH11130696A (ja) * 1997-08-27 1999-05-18 Takeda Chem Ind Ltd 経口徐放性製剤

Also Published As

Publication number Publication date
JP2001316293A (ja) 2001-11-13

Similar Documents

Publication Publication Date Title
US20030040490A1 (en) Drugs containing combined active ingredients
EP1933833B1 (en) Therapy for the treatment of overactive bladder
EP1169037B1 (en) Use of pioglitazone for improving ketosis and acidosis
CN103841988A (zh) 用于治疗2型糖尿病患者的利西拉来和二甲双胍
JP4917712B2 (ja) 併用医薬
KR100709528B1 (ko) 혈당콘트롤용 의약조성물
AU2012253667B2 (en) Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
JP4901218B2 (ja) 併用医薬
US8829018B2 (en) Method of restoring the incretin effect
AU2016301689B2 (en) Ameliorating agent for detrusor hyperactivity with impaired contractility
KR100709531B1 (ko) 당뇨병성 합병증의 예방 또는 진전저지용 의약조성물
US20070275999A1 (en) Pharmaceutical compositions containing a hypoglycemic agent(s) for improving or treating impaired glucose tolerance, borderline diabetes, insulin resistance or hyperinsulinemia
WO2019124860A1 (ko) 시클로-히스프로를 유효성분으로 포함하는 당뇨병 예방 또는 치료용 약제학적 제제
CN110575447A (zh) 一种用于防治糖尿病的药物组合物及其用途
TW592702B (en) Pharmaceutical composition for treating diabetes
WO2007072564A1 (ja) 心不全の治療・予防薬
JP2000080030A (ja) 肉芽腫予防・治療剤
JP2006131564A (ja) 心不全の治療・予防薬
EP1990053A1 (en) Pharmaceutical composition for enhancing adiponectin production
US20040097567A1 (en) Pharmaceutical composition
MX2008002907A (es) Terapia para tratamiento de enfermedad
HK1186123A (en) Therapy for the treatment of disease
NZ617375B2 (en) Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
HK1138182A (en) Methods of lowering glucose levels
JP2010501604A (ja) グルコースレベルを低下させる方法

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070703

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070703

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101130

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111101

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111124

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120124

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120127

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150203

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4917712

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term